Pharmacology

The novel therapy is the first drug for treating cats with hypertrophic cardiomyopathy

American Regent Animal Health created the new resources in collaboration with the UC-Davis professor Denis Marcellin-Little, DEDV, DACVS, DACVSMR, DECVS

Most major sections of the new animal drug application for Laverdia-CA1 have been deemed complete by the FDA, bringing the drug closer to approval

Approved by the FDA in January 2024, EquiCoxib is a noninvasive, liquid formulation.

The legislation seeks to empower law enforcement and fight the opioid epidemic while also protecting access to the drug for veterinary use

Vetigenics is seeing encouraging results of a completed study for an antibody aimed at treating oral melanoma in dogs, used in combination with palliative radition.

Librela (bedinvetmab injection) is a monthly injectable monoclonal antibody, for which real-world drug experience data has been collected in the past year.

Revelation Animal Health, part of the compounding pharmacy network Revelation Pharma, will debut at the 2025 VMX event in Orlando, Florida.

At VMX, Virbac is launching an oral product featuring ursolic acid, in collaboration with Emmyon Inc.

Indications are broadened for Zoetis products to include new protections against Asian longhorned ticks and tapeworms

Integrative therapies can enhance a patient’s survival and quality of life

Neurologic signs were reported with bedinvetmab injection use in dogs

dvm360 is counting down the Top 20 news stories and articles from 2024 with this series of spotlights

dvm360 is counting down the Top 20 news stories and articles from 2024 with this series of spotlights

dvm360 is counting down the Top 20 news stories and articles from 2024 with this series of spotlights

dvm360 is counting down the Top 20 news stories and articles from 2024 with this series of spotlights

dvm360 is counting down the Top 20 news stories and articles from 2024 with this series of spotlights

Covetrus announced the expansion of its' site in Arizona, increasing the company’s pharmacy capabilities for producing compounded products for use in veterinary clinics and pet owners' homes throughout the US

Grey Wolf Animal Health Corp recently acquired the Compounding Pharmacy of Manitoba

The agency approved Bravecto 1-Month for use in treating and controlling Asian longhorned tick infestation

Scripts for confident client conversations

The Phibro Animal Health product is the first of its kind for controlling mortality in some aquatic species

Ethiqa XR now includes captive rodents and laboratory rabbits for 72-hour post-procedural pain management on its label

Canalevia-CA1 is currently the only treatment on the market for treating CID in canine patients.

Vazalore is currently the only FDA-approved human aspirin that may be used in food-producing animals under certain conditions

New York City is piloting a program to reduce breeding with an oral birth control pellet

Bond Vet and Cubex are collaborating to create a safe practice environment through automated drug logging and dispensing

Elanco's lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets (Credelio Quattro) provide a single monthly dose for protection against fleas, ticks, heartworms, roundworms, hookworms, and 3 species of tapeworm.

The drug is one of 22 pharmaceuticals included in a potential ban to aimed at preventing drug related deaths and drug trafficking

The recall involves updating instructions for use, rather than removing devices from where they are used and sold